Home » Microbial Cells Analysis Instrument Market
Microbial Cells Analysis Instrument Market
Published date: Aug 2022 •Formats:
Request Sample Schedule a Call

Global Microbial Cells Analysis Instrument Market By Type (Flow Cytometers, NGS Systems, PCR Instruments, Spectrophotometers, Microscopes, Cell Counters, HCS Systems, and Cell Microarrays), By Application (Noninvasive Prenatal Diagnosis, In Vitro Fertilization, and Circulating Tumor Cell Detection), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2019-2028

  • Published date: Aug 2022
  • Report ID: 35743
  • Number of Pages: 214
  • Format:
  • keyboard_arrow_up
    • 1. Microbial Cells Analysis Instrument Market Introduction
      • 1.1. Definition
      • 1.2. Taxonomy
      • 1.3. Research Scope
    • 2. Executive Summary
      • 2.1. Key Findings by Major Segments
      • 2.2. Top strategies by Major Players
    • 3. Global Microbial Cells Analysis Instrument Market Overview
      • 3.1. Microbial Cells Analysis Instrument Market Dynamics
        • 3.1.1. Drivers
        • 3.1.2. Opportunities
        • 3.1.3. Restraints
        • 3.1.4. Challenges
      • 3.2. PESTLE Analysis
      • 3.3. Opportunity Map Analysis
      • 3.4. PORTER'S Five Forces Analysis
      • 3.5. Market Competition Scenario Analysis
      • 3.6. Product Life Cycle Analysis
      • 3.7. Opportunity Orbits
      • 3.8. Production Analysis by Region/Company
      • 3.9. Industry chain Analysis
      • 3.10. Marketing Strategy
    • 4. Global Microbial Cells Analysis Instrument Market Value & Volume ((US$ Mn & '000 Units)), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
      • 4.1. Global Microbial Cells Analysis Instrument Market Analysis by Type: Introduction
      • 4.2. Market Size and Forecast by Region
      • 4.3. Flow Cytometers
      • 4.4. NGS Systems
      • 4.5. PCR Instruments
      • 4.6. Spectrophotometers
      • 4.7. Microscopes
      • 4.8. Cell Counters
      • 4.9. HCS Systems
      • 4.10. Cell Microarrays
    • 5. Global Microbial Cells Analysis Instrument Market Value & Volume ((US$ Mn & '000 Units)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
      • 5.1. Global Microbial Cells Analysis Instrument Market Analysis by Application: Introduction
      • 5.2. Market Size and Forecast by Region
      • 5.3. Noninvasive Prenatal Diagnosis
      • 5.4. In Vitro Fertilization
      • 5.5. Circulating Tumor Cell Detection
    • 6. Global Microbial Cells Analysis Instrument Market Value & Volume ((US$ Mn & '000 Units)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
      • 6.1. North America
        • 6.1.1. North America Microbial Cells Analysis Instrument Market: Regional Trend Analysis
          • 6.1.1.1. US
          • 6.1.1.2. Canada
          • 6.1.1.3. Mexico
      • 6.2.1. Europe
        • 6.2.1. Europe Microbial Cells Analysis Instrument Market: Regional Trend Analysis
          • 6.2.1.1. Germany
          • 6.2.1.2. France
          • 6.2.1.3. UK
          • 6.2.1.4. Russia
          • 6.2.1.5. Italy
          • 6.2.1.6. Spain
          • 6.2.1.7. Rest of Europe
      • 6.3. Asia-Pacific
        • 6.3.1. Asia-Pacific Microbial Cells Analysis Instrument Market: Regional Trend Analysis
          • 6.3.1.1. China
          • 6.3.1.2. Japan
          • 6.3.1.3. Korea
          • 6.3.1.4. India
          • 6.3.1.5. Rest of Asia-Pacific
      • 6.4. Latin America
        • 6.4.1. Latin America Microbial Cells Analysis Instrument Market: Regional Trend Analysis
          • 6.4.1.1. Brazil
          • 6.4.1.2. Argentina
          • 6.4.1.3. Rest of Latin America
      • 6.5. Middle East and Africa
        • 6.5.1. Middle East and Africa Microbial Cells Analysis Instrument Market: Regional Trend Analysis
          • 6.5.1.1. GCC
          • 6.5.1.2. South Africa
          • 6.5.1.3. Israel
          • 6.5.1.4. Rest of MEA
    • 7. Global Microbial Cells Analysis Instrument Market Competitive Landscape, Market Share Analysis, and Company Profiles
      • 7.1. Market Share Analysis
      • 7.2. Company Profiles
      • 7.3. Merck KGaA (Germany)
        • 7.3.1. Company Overview
        • 7.3.2. Financial Highlights
        • 7.3.3. Product Portfolio
        • 7.3.4. SWOT Analysis
        • 7.3.5. Key Strategies and Developments
      • 7.4. Becton Dickinson and Company (U.S.)
        • 7.4.1. Company Overview
        • 7.4.2. Financial Highlights
        • 7.4.3. Product Portfolio
        • 7.4.4. SWOT Analysis
        • 7.4.5. Key Strategies and Developments
      • 7.5. Promega Corporation (U.S.)
        • 7.5.1. Company Overview
        • 7.5.2. Financial Highlights
        • 7.5.3. Product Portfolio
        • 7.5.4. SWOT Analysis
        • 7.5.5. Key Strategies and Developments
      • 7.6. Danaher Corporation (U.S.)
        • 7.6.1. Company Overview
        • 7.6.2. Financial Highlights
        • 7.6.3. Product Portfolio
        • 7.6.4. SWOT Analysis
        • 7.6.5. Key Strategies and Developments
      • 7.7. General ElectricCompany (U.K.)
        • 7.7.1. Company Overview
        • 7.7.2. Financial Highlights
        • 7.7.3. Product Portfolio
        • 7.7.4. SWOT Analysis
        • 7.7.5. Key Strategies and Developments
      • 7.8. Thermo Fisher Scientific Inc. (U.S.)
        • 7.8.1. Company Overview
        • 7.8.2. Financial Highlights
        • 7.8.3. Product Portfolio
        • 7.8.4. SWOT Analysis
        • 7.8.5. Key Strategies and Developments
      • 7.9. Thermo Fisher Scientific Inc. (U.S.)
        • 7.9.1. Company Overview
        • 7.9.2. Financial Highlights
        • 7.9.3. Product Portfolio
        • 7.9.4. SWOT Analysis
        • 7.9.5. Key Strategies and Developments
      • 7.10. Illumina inc. (U.S.)
        • 7.10.1. Company Overview
        • 7.10.2. Financial Highlights
        • 7.10.3. Product Portfolio
        • 7.10.4. SWOT Analysis
        • 7.10.5. Key Strategies and Developments
      • 7.11. Bio-Rad Laboratories inc.(U.S.)
        • 7.11.1. Company Overview
        • 7.11.2. Financial Highlights
        • 7.11.3. Product Portfolio
        • 7.11.4. SWOT Analysis
        • 7.11.5. Key Strategies and Developments
      • 7.12. Fluidigm Corporation (U.S.)
        • 7.12.1. Company Overview
        • 7.12.2. Financial Highlights
        • 7.12.3. Product Portfolio
        • 7.12.4. SWOT Analysis
        • 7.12.5. Key Strategies and Developments
      • 7.13. NanoString Technologies inc. (U.S.)
        • 7.13.1. Company Overview
        • 7.13.2. Financial Highlights
        • 7.13.3. Product Portfolio
        • 7.13.4. SWOT Analysis
        • 7.13.5. Key Strategies and Developments
      • 7.14. Agilent Technologies (U.S.)
        • 7.14.1. Company Overview
        • 7.14.2. Financial Highlights
        • 7.14.3. Product Portfolio
        • 7.14.4. SWOT Analysis
        • 7.14.5. Key Strategies and Developments
      • 7.15. Abcam Plc (U.S.)
        • 7.15.1. Company Overview
        • 7.15.2. Financial Highlights
        • 7.15.3. Product Portfolio
        • 7.15.4. SWOT Analysis
        • 7.15.5. Key Strategies and Developments
      • 7.16. NuGEN Technologies Inc. (U.S.)
        • 7.16.1. Company Overview
        • 7.16.2. Financial Highlights
        • 7.16.3. Product Portfolio
        • 7.16.4. SWOT Analysis
        • 7.16.5. Key Strategies and Developments
      • 7.17. LumaCyte (U.S.)
        • 7.17.1. Company Overview
        • 7.17.2. Financial Highlights
        • 7.17.3. Product Portfolio
        • 7.17.4. SWOT Analysis
        • 7.17.5. Key Strategies and Developments
      • 7.18. PluriSelect Life Science UG & Co. KG (Germany)
        • 7.18.1. Company Overview
        • 7.18.2. Financial Highlights
        • 7.18.3. Product Portfolio
        • 7.18.4. SWOT Analysis
        • 7.18.5. Key Strategies and Developments
      • 7.19. Sysmex Partec(U.S.)
        • 7.19.1. Company Overview
        • 7.19.2. Financial Highlights
        • 7.19.3. Product Portfolio
        • 7.19.4. SWOT Analysis
        • 7.19.5. Key Strategies and Developments
      • 7.20. Bio-Techne Corporation (U.S.)
        • 7.20.1. Company Overview
        • 7.20.2. Financial Highlights
        • 7.20.3. Product Portfolio
        • 7.20.4. SWOT Analysis
        • 7.20.5. Key Strategies and Developments
    • 8. Assumptions and Acronyms
    • 9. Research Methodology
    • 10. Contact
    • Merck KGaA (Germany)
    • Becton Dickinson and Company (U.S.)
    • Promega Corporation (U.S.)
    • Danaher Corporation (U.S.)
    • General ElectricCompany (U.K.)
    • Thermo Fisher Scientific Inc. (U.S.)
    • Illumina inc. (U.S.)
    • Bio-Rad Laboratories inc.(U.S.)
    • Fluidigm Corporation (U.S.)
    • NanoString Technologies inc. (U.S.)
    • Agilent Technologies (U.S.)
    • Abcam Plc (U.S.)
    • NuGEN Technologies Inc. (U.S.)
    • LumaCyte (U.S.)
    • PluriSelect Life Science UG & Co. KG (Germany)
    • Sysmex Partec(U.S.)
    • Bio-Techne Corporation (U.S.)
  • settingsSettings

Related Reports

Our Clients

  • Our Clients
Inquiry Before Buying

Microbial Cells Analysis Instrument Market
  • 35743
  • Aug 2022
    • ★★★★★
      ★★★★★
    • (27)
  • US $5,999
    US $2,999
  • US $7,999
    US $3,499
  • US $12,999
    US $4,499
Buy Now
✖
Request a Sample Report
We'll get back to you as quickly as possible

Single User
$5,999
$2,999
USD / per unit
save 50%
 Multi User
$7,999
$3,499
USD / per unit
save 55%
 Corporate User
$12,999
$4,499
USD / per unit
save 65%
e-Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization No up to 10 hrs work up to 30 hrs work
Accessibility 1 User 2-5 User Unlimited
Analyst Support up to 20 hrs up to 40 hrs up to 50 hrs
Benefit Up to 20% off on next purchase Up to 25% off on next purchase Up to 30% off on next purchase
Buy Now ($ 2,999)Buy Now ($ 3,499)Buy Now ($ 4,499)
Find Help
Legal
Explore